bexagliflozin

Bexagliflozin, sold under the brand name Brenzavvy, is an antidiabetic medication used to improve glycemic control in adults with type 2 diabetes. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that is taken by mouth.

In the Vinony graph

Within Vinony's link graph, bexagliflozin is referenced by 34 other articles, and connects out to metformin, anti-diabetic medication and alogliptin.

Vinony files it under Cat medications, Chloroarenes and Cyclopropyl compounds.

Its subject is documented across 8 Wikipedia language editions.

Chemical data

Formula: C24H29ClO7
Molecular weight: 464.9 g/mol
IUPAC name: (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
SMILES: C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl
InChIKey: BTCRKOKVYTVOLU-SJSRKZJXSA-N
XLogP: 2.4
Polar surface area: 109 Å²
H-bond donors: 4
H-bond acceptors: 7
Formal charge: 0

via PubChem

Drug data · ChEMBL

Max clinical phase: Approved
Molecule type: Small molecule
First approval: 2023
Admin. routes: oral
Indications: diabetes mellitus, essential hypertension, type 2 diabetes mellitus

via ChEMBL · EBI

Wikidata facts

Instance of: gliflozins
Subclass of: chemical compound
Mass: 464.16

Show 5 more facts

canonical SMILES: C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl
chemical formula: C₂₄H₂₉ClO₇
isomeric SMILES: C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl
subject has role: veterinary drug
Commons category: Bexagliflozin

Sources (1)